Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
[Comparison of the efficacy and safety of 2 low-dose rituximab regimens in the second-line treatment of primary immune thrombocytopenia in children].
Zhonghua Er Ke Za Zhi. 2022 Nov 2;60(11):1185-1190. doi: 10.3760/cma.j.cn112140-20220418-00340.
Zhonghua Er Ke Za Zhi. 2022.
PMID: 36319155
Chinese.
[Clinical and genetic features of seven children with MYH9-related disease].
Hu Y, Ma JY, Liu HQ, Yang BX, Zhao SS, Zhang JL, Wu RH.
Hu Y, et al.
Zhonghua Er Ke Za Zhi. 2021 Nov 2;59(11):968-972. doi: 10.3760/cma.j.cn112140-20210809-00657.
Zhonghua Er Ke Za Zhi. 2021.
PMID: 34711033
Chinese.
Item in Clipboard
High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study.
Ma J, Fu L, Chen Z, Gu H, Ma J, Wu R.
Ma J, et al.
Int J Hematol. 2020 Dec;112(6):773-779. doi: 10.1007/s12185-020-02977-9. Epub 2020 Sep 3.
Int J Hematol. 2020.
PMID: 32885352
Clinical Trial.
Item in Clipboard
Cite
Cite